130 related articles for article (PubMed ID: 16345039)
1. A Bayesian stopping rule for a single arm study: With a case study of stem cell transplantation.
Chen C; Chaloner K
Stat Med; 2006 Sep; 25(17):2956-66. PubMed ID: 16345039
[TBL] [Abstract][Full Text] [Related]
2. Sequential clinical trials for normal variates using interval composite hypotheses.
Lachin JM
Biometrics; 1981 Mar; 37(1):87-101. PubMed ID: 7248445
[TBL] [Abstract][Full Text] [Related]
3. Bayesian decision sequential analysis with survival endpoint in phase II clinical trials.
Zhao L; Woodworth G
Stat Med; 2009 Apr; 28(9):1339-52. PubMed ID: 19226557
[TBL] [Abstract][Full Text] [Related]
4. Bayesian design of single-arm phase II clinical trials with continuous monitoring.
Johnson VE; Cook JD
Clin Trials; 2009 Jun; 6(3):217-26. PubMed ID: 19528131
[TBL] [Abstract][Full Text] [Related]
5. Frequentist evaluation of group sequential clinical trial designs.
Emerson SS; Kittelson JM; Gillen DL
Stat Med; 2007 Dec; 26(28):5047-80. PubMed ID: 17573678
[TBL] [Abstract][Full Text] [Related]
6. Early stopping rules in clinical trials based on sequential monitoring of serious adverse events.
Kramar A; Bascoul-Mollevi C
Med Decis Making; 2009; 29(3):343-50. PubMed ID: 19073996
[TBL] [Abstract][Full Text] [Related]
7. Alloreactivity as therapeutic principle in the treatment of hematologic malignancies. Studies of clinical and immunologic aspects of allogeneic hematopoietic cell transplantation with nonmyeloablative conditioning.
Petersen SL
Dan Med Bull; 2007 May; 54(2):112-39. PubMed ID: 17521527
[TBL] [Abstract][Full Text] [Related]
8. Bayesian predictive approach to interim monitoring in clinical trials.
Dmitrienko A; Wang MD
Stat Med; 2006 Jul; 25(13):2178-95. PubMed ID: 16007570
[TBL] [Abstract][Full Text] [Related]
9. Bayesian monitoring of clinical trials with failure-time endpoints.
Rosner GL
Biometrics; 2005 Mar; 61(1):239-45. PubMed ID: 15737099
[TBL] [Abstract][Full Text] [Related]
10. Unrelated umbilical cord blood transplantation for adults with haematological malignancies: results from a single Australian centre.
Bradstock KF; Hertzberg MS; Kerridge IH; Svennilson J; McGurgan M; Huang G; Antonenas V; Gottlieb DJ
Intern Med J; 2006 Jun; 36(6):355-61. PubMed ID: 16732860
[TBL] [Abstract][Full Text] [Related]
11. Bayesian evaluation of group sequential clinical trial designs.
Emerson SS; Kittelson JM; Gillen DL
Stat Med; 2007 Mar; 26(7):1431-49. PubMed ID: 17066402
[TBL] [Abstract][Full Text] [Related]
12. Statistical rules for safety monitoring in clinical trials.
Martens MJ; Logan BR
Clin Trials; 2024 Apr; 21(2):152-161. PubMed ID: 37877375
[TBL] [Abstract][Full Text] [Related]
13. Clinical use of umbilical cord blood hematopoietic stem cells.
Rocha V; Gluckman E;
Biol Blood Marrow Transplant; 2006 Jan; 12(1 Suppl 1):34-41. PubMed ID: 16399582
[TBL] [Abstract][Full Text] [Related]
14. Bayesian interim analysis in clinical trials.
Zhang X; Cutter G
Contemp Clin Trials; 2008 Sep; 29(5):751-5. PubMed ID: 18589003
[TBL] [Abstract][Full Text] [Related]
15. Study duration for clinical trials with survival response and early stopping rule.
Kim K; Tsiatis AA
Biometrics; 1990 Mar; 46(1):81-92. PubMed ID: 2350572
[TBL] [Abstract][Full Text] [Related]
16. Bayesian predictive power for interim adaptation in seamless phase II/III trials where the endpoint is survival up to some specified timepoint.
Schmidli H; Bretz F; Racine-Poon A
Stat Med; 2007 Nov; 26(27):4925-38. PubMed ID: 17590875
[TBL] [Abstract][Full Text] [Related]
17. [Umbilical cord blood as a source of stem cells].
Bojanić I; Golubić Cepulić B
Acta Med Croatica; 2006 Jun; 60(3):215-25. PubMed ID: 16933834
[TBL] [Abstract][Full Text] [Related]
18. [Unrelated umbilical cord blood transplantation as a treatment for children with malignant leukemia].
Tang XF; Luan Z; Xu SX; Wu NH; Huang YZ; Wang K
Zhongguo Dang Dai Er Ke Za Zhi; 2008 Feb; 10(1):5-8. PubMed ID: 18289460
[TBL] [Abstract][Full Text] [Related]
19. Leukemia: cord blood for allogeneic stem cell transplantation.
Takahashi S
Curr Opin Oncol; 2007 Nov; 19(6):667-72. PubMed ID: 17906469
[TBL] [Abstract][Full Text] [Related]
20. Issues in the use of adaptive clinical trial designs.
Emerson SS
Stat Med; 2006 Oct; 25(19):3270-96; discussion 3302-4, 3320-5, 3326-47. PubMed ID: 16906553
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
